Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Jinda Pharmaceutical Chemistry is a China-based pharmaceutical manufacturer focused on active pharmaceutical ingredients (APIs) and related intermediates. The company appears to operate primarily as a commercial supplier for generic drug manufacturers rather than as an innovative drug developer, with marketed API capabilities spanning products such as dantrolene sodium, carprofen, nitrofurazone, nitrofurantoin, trospium chloride, rosuvastatin calcium, sodium foscarnet, sotalol hydrochloride, and entecavir. Publicly available supplier profiles indicate that the company holds China GMP certification, has undergone multiple US FDA inspections, and has filed DMFs and related regulatory dossiers to support customer registrations in regulated markets. Its business is centered on manufacturing, quality systems, and international export of small-molecule pharmaceutical ingredients from Jinan, Shandong, China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Jinda Pharmaceutical Chemistry.